Ziyan Zhao
Academy of Medical Sciences, United Kingdom
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ziyan Zhao.
Biomedicine & Pharmacotherapy | 2000
Ram B. Singh; Andi Weydahl; K. Otsuka; Yoshihiko Watanabe; S. Yano; H. Mori; Y. Ichimaru; G. Mitsutake; Y. Sato; L. Fanghong; Ziyan Zhao; C. Kartik; A. Gvozdjakova
Recent studies indicate that there is an interaction between biorhythms, the biological clock and triggers, which may be important in the pathogenesis of altered heart rate variability (HRV) and blood pressure variability (BPV). Circadian rhythms are under the influence of, and physiological variables are mediated by the activation of the adrenals, sympathetic/parasympathetic, hypothalamic and pituitary activity. Emotional stress, physical exertion, sleep deprivation and large fatty meals are major triggers of myocardial ischemia, angina, infarction, sudden cardiac death (SCD) and stroke. These events have been reported to exhibit a circadian variation with increased frequency in the second quarter of the day, which has also been observed in our studies on Indians. Recent studies indicate that altered HRV and BPV are also important in the pathogenesis and progression of heart failure, atheroma and thrombosis. Mediation via beta-blockers, oestrogens, n-3 fatty acids, vitamin E and coenzyme Q10 and fasting appears to have a beneficial influence whereas progestins, nifedipine, stress and exercise may have an adverse effect on HRV and BPV. We have reported that plasma levels of vitamin E and C are lower in the second quarter of the day than at other times, indicating their role in the pathogenesis of variability and cardiac events. Prospective studies also indicate that HRV and BPV are important and independent risk factors for cardiovascular events. However, no study has yet been conducted in patients with abnormal HRV and BPV in a randomized, placebo-controlled intervention trial to find out whether improvement in variability can cause a significant reduction in cardiovascular events. There is a need to study the role of n-3 fatty acids, coenzyme Q10, the effect of regular physical training, medication and ACE inhibitors in patients with abnormal HRV and BPV to demonstrate that improving variability can modulate cardiovascular events.
Biomedicine & Pharmacotherapy | 2005
G. Cornélissen; Alain Delcourt; Guy Toussaint; K. Otsuka; Yoshihiko Watanabe; Jarmila Siegelová; Bohumil Fišer; Jiří Dušek; Pavel Homolka; R. B. Singh; A. Kumar; Ranjana Singh; S. Sanchez; C. Gonzalez; Daniel C. Holley; B. Sundaram; Ziyan Zhao; Brian Tomlinson; B. Fok; Michal Zeman; Katarina Dulkova; Franz Halberg
Overswinging or CHAT (brief for Circadian Hyper-Amplitude-Tension), that is an excessive circadian variation in blood pressure (BP), has been associated with a large increase in cardiovascular disease risk, present even in the absence of an elevated BP itself. This usually asymptomatic condition is usually overlooked by current practice based on spot-checks, because to be diagnosed, measurements need to be taken around-the-clock, preferably for 7 days at the outset. Once diagnosed, however, a usual circadian BP pattern can be restored by means of certain non-pharmacologic or pharmacologic interventions timed appropriately. Thereby, it is possible to reduce the risk of cardiovascular morbidity and mortality, cerebral ischemic events and nephropathy in particular. For the preparation of guidelines regarding the diagnosis of BP disorders and for the institution of primary as well as secondary preventive measures, it is important to know what the incidence of CHAT is on a global basis. We found 191 cases of CHAT among 1602 mostly 7-day/24-h BP profiles, obtained from several centers in different countries participating in an ongoing project on the BIOsphere and the COSmos (BIOCOS). CHAT incidence is about the same between men and women, but it is diagnosed more often among patients with borderline hypertension or with glucose intolerance. It is also more common among MESOR-hypertensive than among MESOR-normotensive individuals. Priority should be given to the development of an unobtrusive and affordable device to automatically monitor BP and to analyze the data as-one-goes, so that cardiovascular disease risk can be prevented.
Neuroendocrinology Letters | 2000
Franz Halberg; G. Cornélissen; K. Otsuka; Yoshihiko Watanabe; G. Katinas; Naoto Burioka; Anatoly Delyukov; Gorgo Y; Ziyan Zhao; Andi Weydahl; Robert B. Sothern; Jarmila Siegelová; Bohumil Fišer; Jiří Dušek; Elena V. Syutkina; Federico Perfetto; Roberto Tarquini; Ram B. Singh; Rhees B; Lofstrom D; Lofstrom P; P Johnson; Othild Schwartzkopff
International Journal of Cardiology | 2003
Ram B. Singh; Germaine Cornélissen; Andi Weydahl; Othild Schwartzkopff; G. Katinas; Kuniaki Otsuka; Yoshihiko Watanabe; S. Yano; Hideki Mori; Yuhei Ichimaru; G. Mitsutake; Daniel Pella; Lu Fanghong; Ziyan Zhao; Reema S Rao; Gvozdjáková A; Franz Halberg
Journal of Anti-aging Medicine | 1998
Franz Halberg; Germaine Cornélissen; Julia Halberg; Henry Fink; Chen-Huan Chen; Kuniaki Otsuka; Yoshihiko Watanabe; Yuji Kumagai; Elena V. Syutkina; Terukazu Kawasaki; Keiko Uezono; Ziyan Zhao; Othild Schwartzkopff
World Heart Journal | 2008
Germaine Cornélissen; Franz Halberg; R. B. Singh; Lusine Manukyan; Elchin Khalilov; Jean De Prins; Alain Delcourt; Christian Deruyck; Guy Toussaint; Christian Muller; Olga Quadens; Luiz Menna Barreto; Zhengrong Wang; Jinyi Wu; Ziyan Zhao; Jiri Dusek; Bohumil Fišer; Pavel Homolka; P. Prikryl; Jarmila Siegelová; Jaroslav Strestik; Christine Amory-Mazaudier; Sigrid Berger; Karl Hecht; Rita Jozsa; Atanu Kumar Pati; R. K. Singh; Franca Carandente; Cristina Maggioni; Giacomo Laffi
Neuroendocrinology Letters | 2003
Germaine Cornélissen; Franz Halberg; Othild Schwartzkopff; G. Katinas; Dana E. Johnson; Kuniaki Otsuka; Yoshihiko Watanabe; Zhengrong Wang; Chaomin Wan; Federico Perfetto; Roberto Tarquini; Cristina Maggioni; Elena V. Syutkina; Anatoly Masalov; Jarmila Siegelová; Ziyan Zhao; R. B. Singh; R. Singh; Anatoly Delyukov; Yuri Gorgo; Rina M. Zaslavskaya; Gennady D. Gubin; Denis Gubin; Yuji Kumagai; Keiko Uezono; Douglas Wilson; Andi Weydahl; Earl E. Bakken
/data/revues/07533322/005900S1/0580023X/ | 2008
G. Cornélissen; Alain Delcourt; Guy Toussaint; K. Otsuka; Yoshihiko Watanabe; Jarmila Siegelová; Bohumil Fišer; Jiří Dušek; Pavel Homolka; R. B. Singh; Adarsh Kumar; R. K. Singh; S. Sanchez; C. Gonzalez; Daniel C. Holley; Balasasikumar Sundaram; Ziyan Zhao; Brian Tomlinson; B. Fok; Michal Zeman; Katarina Dulkova; Franz Halberg
Scripta Medica Facultatis Medicae Universitatis Brunensis Masarykianae | 2006
G. Cornélissen; Franz Halberg; G. Katinas; Othild Schwartzkopff; Daniel C. Holley; Katarina T. Borer; Pavel Homolka; Jarmila Siegelová; Bohumil Fišer; Jiří Dušek; K. Otsuka; A. Yano; A. Delcourt; G. Toussaint; S. Sánchez de la Peña; C. Gonzalez; Ziyan Zhao; N. Aslanian; R. B. Singh; Adarsh Kumar; Roberto Tarquini; Federico Perfetto
Biomedicine & Pharmacotherapy | 2005
G. Cornélissen; Alain Delcourt; G. Toussaint; Kuniaki Otsuka; Yoshihiko Watanabe; Jarmila Siegelová; Bohumil Fišer; Jiří Dušek; Pavel Homolka; R. B. Singh; S. Sanchez; C. Gonzales; Daniel C. Holley; B. Sudandaram; Ziyan Zhao; B. Tomlison; B. Fok; Michal Zeman; K. Dulkova; F. Halberg